Financial toxicity describes the financial burden and distress that can arise for patients, and
their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for …

In this report, the authors provide comprehensive and up‐to‐date US data on disparities in
cancer occurrence, major risk factors, and access to and utilization of preventive measures …

Background To achieve equitable access to cancer clinical trials (CCTs), patients must
overcome structural, clinical, and attitudinal barriers to trial enrollment. The goal of this …

The mismatch between the study populations participating in oncology clinical trials and the
composition of the targeted cancer population requires urgent amelioration. Regulatory …

Objective To evaluate disparities in financial toxicity and psychological distress in patients
with cancer as a function of treatment and reveal the relationship between financial toxicity …

PURPOSE Financial hardship (FH) is a complex issue in cancer care, affecting material
conditions, well-being, and coping behaviors. This study aimed to longitudinally examine …

Objective To develop a comprehensive understanding of financial toxicity (FT) among
patients with lung cancer in China and the major factors affecting FT. Methods Drawing from …

Despite progress toward equity within our broad social context, the domains of gender as a
social, cultural, and structural variable continue to exert influence on the delivery of oncology …

Financial toxicity occurs when patients, families, and households experience “financial
burden and distress” as a result of their healthcare expenses. 1, 2 To date, most research on …

Phase I trials often represent the first occasion where new cancer strategies are tested in
patients. Various developments in cancer biology, methodology, regulation, and medical …